Reckless ReMarcs: Mylan CEO in Hot Seat for Drastic EpiPen Pricing
The Remarc: In an interview with CNBC on Thursday, Mylan CEO Heather Bresch received massive criticism in attempt to vindicate her company’s skyrocketing EpiPen prices. She claimed,“No one is more frustrated than me”. The Issue: Heather Bresch was the one who boosted the price of EpiPens by 400%...